Accessibility Menu
Lucy Scientific Discovery logo

Lucy Scientific Discovery(OTC) LSDI

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2023)-100%
5 YearN/A
1 Year-50%
1 Month+0%
N/A
Lucy Scientific Discovery last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-27
Lucy Scientific Discovery stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-12
1 month+0%USD 0.002026-07-28
3 month+0%USD 0.002026-05-18
Year to date-66.67%USD 0.002025-12-31
1 year-50%USD 0.002025-08-26
3 year-100%USD 5.692023-08-28
Since inception-100%USD 29.902023-02-09

Lucy Scientific Discovery Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$16.73K

Net Income (TTM)

-$12.67M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Jul 3, 2024

LSDI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lucy Scientific Discovery

Lucy Scientific Discovery Inc. is a company dedicated to the entire lifecycle of psychedelic products, encompassing research, development, production, and market release. Established in 2017 and headquartered in Victoria, Canada, the company offers a range of biological raw materials, unprocessed extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs).

Products and Services
  • Biological raw materials for psychedelic research
  • Unprocessed extracts and psychotropic compounds
  • Active pharmaceutical ingredients (APIs) for drug formulation
Growth Outlook
  • Market demand for psychedelics is increasing significantly
  • Expansion into new therapeutic areas is planned
  • Strategic partnerships are being explored to enhance capabilities
Financial Highlights
  • Recent quarterly revenue of $9,684, showing initial market traction
  • Trailing twelve months (TTM) revenue of $10,732, indicating growth potential
  • Cash and short-term investments totaled $211,120 as of December 31, 2023
Lucy Scientific Discovery Inc. operates in the rapidly evolving field of psychedelics, which is gaining traction for its therapeutic potential. The company's focus on the entire lifecycle of psychedelic products positions it well to capitalize on emerging market opportunities. Recent financial data indicates a modest revenue generation, with a quarterly revenue of $9,684, suggesting initial market traction. The TTM revenue of $10,732 reflects the company's potential for growth as it navigates the expanding landscape of psychedelic therapies. With a cash position of $211,120, the company is poised to explore strategic partnerships and expand its offerings, aligning with the increasing demand for innovative therapeutic solutions.
AI Generated • Aug 15, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Christopher McElvany

Website

www.lucyscientific.com

Headquarters

Victoria, BC V8W 0B6, CA

LSDI Financials

Key Financial Metrics (TTM)

Gross Margin

36.15%

Operating Margin

-82919.74%

Net Income Margin

-127532.01%

Return on Equity

18147.32%

Return on Capital

-90.36%

Return on Assets

-102.39%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$112.75K

Operating Income

-$6.96M

EBITDA

-$8.50M

Operating Cash Flow

-$5.50M

Capital Expenditure

-$421.28K

Free Cash Flow

-$5.92M

Cash & ST Invst.

$211.12K

Total Debt

$1.36M

Lucy Scientific Discovery Performance Analysis

Lucy Scientific Discovery annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 0N/A
20232023-06-30USD 7,048N/A
Lucy Scientific Discovery sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-03-31N/A
Q42023-06-30N/A
Q12023-09-30-100.0%
Q22023-12-31N/A
Lucy Scientific Discovery annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD -3.65N/A
20232023-06-30USD -7.0894.0%
Lucy Scientific Discovery sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-03-31-178.6%
Q42023-06-3061.5%
Q12023-09-3026.7%
Q22023-12-31-45.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$9.68K

N/A

Gross Profit

-$13.39K

+51.6%

Gross Margin

-1.38%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

2

N/A

Net Income

-$2.81M

-98.1%

EBITDA

-$1.16M

-174.7%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$211.12K

+710.2%

Total Debt

$1.36M

-78.5%

Accounts Receivable

$8.98K

-75.7%

Inventory

$0.00

N/A

Long Term Debt

$719.37K

-74.3%

Short Term Debt

$643.51K

-81.8%

Return on Assets

-1.02%

N/A

Return on Invested Capital

-96.30%

N/A

Free Cash Flow

-$317.39K

-155.1%

Operating Cash Flow

-$318.34K

-155.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NEPTFNeptune Wellness Solutions Inc.
$0.00+0.00%
NVIVInVivo Therapeutics Holdings Corporation
$0.32-34.28%
PAVMPAVmed Inc.
$5.21+5.89%
NMTRQ9 Meters Biopharma, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About LSDI

What is the current price of Lucy Scientific Discovery?

Lucy Scientific Discovery is trading at N/A per share.

What is the 52-week range for Lucy Scientific Discovery?

Over the past 52 weeks, Lucy Scientific Discovery has traded between N/A and N/A.

How much debt does Lucy Scientific Discovery have?

As of the most recent reporting period, Lucy Scientific Discovery reported total debt of $1.79M.

How much cash does Lucy Scientific Discovery have on hand?

Lucy Scientific Discovery reported $1.67M in cash and cash equivalents in its most recent financial results.

What is Lucy Scientific Discovery’s dividend yield?

Lucy Scientific Discovery does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services